Omeros (OMER) Receivables - Net (2010 - 2026)
Omeros' (OMER) quarterly Receivables - Net came in at $12.0 million in Q1 2026, up 70.04% year-on-year from $7.1 million in Q1 2025, and up 10.21% quarter-over-quarter from $10.9 million in Q4 2025.
Omeros (OMER) Receivables - Net (2010 - 2026) Analysis & Trends
Omeros has disclosed Receivables - Net across 17 years of filings, most recently posting $12.0 million for Q1 2026.
- Receivables - Net for Q1 2026 came in at $12.0 million, up 70.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.0 million (up 70.04% YoY), and the FY2025 annual result was $10.9 million, up 41.06% from the prior year.
- Receivables - Net came in at $12.0 million for Q1 2026 at Omeros, up from $10.9 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $213.2 million in Q4 2022 to a low of $6.3 million in Q2 2025.
- The 5-year median for Receivables - Net is $8.1 million (2024), against an average of $21.4 million.
- Across the five-year window, Receivables - Net soared 20501.06% in 2022 and plunged 96.2% in 2023, its largest moves.
- Omeros' Receivables - Net stood at $213.2 million in 2022, then slumped by 96.2% to $8.1 million in 2023, then slipped by 4.41% to $7.7 million in 2024, then jumped by 41.06% to $10.9 million in 2025, then gained by 10.21% to $12.0 million in 2026.
- The last three Receivables - Net figures came in at $12.0 million (Q1 2026), $10.9 million (Q4 2025), and $6.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.03 Mn |
| Mar 31, 2026 | 12.03 Mn |
| Dec 31, 2025 | 10.92 Mn |
| Dec 31, 2025 | 10.92 Mn |
| Sep 30, 2025 | 6.91 Mn |
| Sep 30, 2025 | 6.91 Mn |
| Jun 30, 2025 | 6.28 Mn |
| Jun 30, 2025 | 6.28 Mn |
| Mar 31, 2025 | 7.08 Mn |
| Mar 31, 2025 | 7.08 Mn |
| Dec 31, 2024 | 7.74 Mn |
| Dec 31, 2024 | 7.74 Mn |
| Sep 30, 2024 | 6.39 Mn |
| Sep 30, 2024 | 6.39 Mn |
| Jun 30, 2024 | 8.08 Mn |
| Jun 30, 2024 | 8.08 Mn |
| Mar 31, 2024 | 7.64 Mn |
| Mar 31, 2024 | 7.64 Mn |
| Dec 31, 2023 | 8.10 Mn |
| Dec 31, 2023 | 8.10 Mn |